Craig Venter and others have constructed synthetic copies of viral genomes. For example, the genome for poliovirus and the 1918 influenza strain responsible for the pandemic flu have been assembled this way. The United States currently has a moratorium on federal funding for 'gain-of-function' experiments which increase the virulence or transmission potential of viruses. What concerns might ethicists have about synthetic biology studies involving potential pandemic pathogens?

Verified step by step guidance

Step 1: Understand the concept of synthetic biology, which involves designing and constructing new biological parts, devices, and systems, or re-designing existing natural biological systems for useful purposes, such as creating synthetic viral genomes.

Step 2: Recognize that 'gain-of-function' experiments refer to research that enhances the ability of a pathogen to cause disease or spread, which can increase the risk associated with handling such organisms.

Step 3: Identify the ethical concerns related to synthetic biology studies on potential pandemic pathogens, including the risk of accidental release of a highly virulent or transmissible virus that could cause widespread disease.

Step 4: Consider the dual-use dilemma, where research intended for beneficial purposes (like understanding viruses) could also be misused for harmful purposes, such as bioterrorism or creating more dangerous pathogens.

Step 5: Reflect on the importance of regulatory oversight, transparency, and risk-benefit analysis in conducting such research to balance scientific advancement with public safety and ethical responsibility.

Verified video answer for a similar problem:

This video solution was recommended by our tutors as helpful for the problem above.

Video duration:

Was this helpful?

Key Concepts

Here are the essential concepts you must grasp in order to answer the question correctly.

Synthetic Biology and Genome Synthesis

Synthetic biology involves designing and constructing new biological parts or entire genomes, such as viral genomes, using chemical synthesis. This technology enables scientists to recreate or modify organisms at the genetic level, which can help study viruses but also raises concerns about creating potentially harmful pathogens.

Gain-of-Function Research

Gain-of-function research refers to experiments that enhance the properties of organisms, such as increasing a virus's transmissibility or virulence. While it can provide insights into disease mechanisms and preparedness, it poses risks of accidental release or misuse, leading to ethical debates and regulatory moratoria.

Ethical and Biosafety Concerns in Pandemic Pathogen Research

Ethicists worry that synthetic biology studies on dangerous pathogens might lead to accidental outbreaks, bioterrorism, or unintended consequences. They emphasize the need for strict oversight, risk assessment, and balancing scientific benefits against public health and safety risks.

Recommended video:

Guided course

07:11

Mapping with Markers

Related Practice

Textbook Question

A number of mouse models for human cystic fibrosis (CF) exist. Each of these mouse strains is transgenic and bears a different specific CFTR gene mutation. The mutations are the same as those seen in several varieties of human CF. These transgenic CF mice are being used to study the range of different phenotypes that characterize CF in humans. They are also used as models to test potential CF drugs. Unfortunately, most transgenic mouse CF strains do not show one of the most characteristic symptoms of human CF, that of lung congestion. Can you think of a reason why mouse CF strains do not display this symptom of human CF?

Textbook Question

In 2010, a U.S. District Judge ruled to invalidate Myriad Genetics' patents on the BRCA1 and BRCA2 genes. Judge Sweet noted that since the genes are part of the natural world, they are not patentable. Myriad Genetics also holds patents on the development of a direct-to-consumer test for the BRCA1 and BRCA2 genes.

Would you agree with the ruling to invalidate the patenting of the BRCA1 and BRCA2 genes? If you were asked to judge the patenting of the direct-to-consumer test for the BRCA1 and BRCA2 genes, how would you rule?

Textbook Question

J. Craig Venter has filed a patent application for his 'first-ever human-made life form.' This patent is designed to cover the genome of M. genitalium. Would your ruling for Venter's 'organism' be different from the judge's ruling on patenting of the BRCA1 and BRCA2 genes?